N.J. Federal Judge Partially Dismisses Claims In Amended Insulin Pricing Dispute
NEWARK, N.J. — A New Jersey federal judge denied a motion to strike a fourth amended complaint alleging that three drug manufacturers engaged in an unfair and unconscionable pricing scheme for...To view the full article, register now.
Already a subscriber? Click here to view full article